Showing results (261-270 of 348) with videos related to

Sort By:
Pageof 35
Cancer Treatment Reports|May 1, 1983
Phase I trial of mitoxantrone by 24-hour continuous infusionK C Anderson, M B Garnick, M W Meshad, et al.
Cancer Treatment Reports|November 1, 1984
Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologiesK C Anderson, A T Skarin, D S Rosenthal, et al.
Blood|July 1, 1990
T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complicationsK C Anderson, R Soiffer, R DeLage, et al.
Transfusion|February 1, 1996
Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte-colony-stimulating factor: implications for yield of hematopoietic progenitor cell collectionsI J Webb, C E Eickhoff, A D Elias, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 26, 2019
Therapeutic plasma exchange in neurological disorders: Experience from a tertiary neuroscience centreJoyutpal Das, Vanisha D Chauhan, Daniel Mills, et al.
Retina (Philadelphia, Pa.)|January 1, 1983
The evaluation of patients with Eales' diseaseW A Renie, R P Murphy, K C Anderson, et al.
Bone Marrow Transplantation|May 1, 1989
Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipientsL D Bosserman, C Murray, T Takvorian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrowR J Soiffer, C Murray, P Mauch, et al.
British Journal of Haematology|August 8, 1998
Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myelomaM L Grossbard, P Fidias, J Kinsella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot studyA S Freedman, T Takvorian, D Neuberg, et al.
Pageof 35